AYTU BIOPHARMA, INC Quarterly Nonoperating Income (Expense) in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Aytu Biopharma, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2010 to Q3 2023.
  • Aytu Biopharma, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$6.62M, a 698% decline year-over-year.
  • Aytu Biopharma, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$7.71M, a 424% decline year-over-year.
  • Aytu Biopharma, Inc annual Nonoperating Income (Expense) for 2023 was $14K, a 98.6% decline from 2022.
  • Aytu Biopharma, Inc annual Nonoperating Income (Expense) for 2022 was $1.02M, a 21.1% increase from 2021.
  • Aytu Biopharma, Inc annual Nonoperating Income (Expense) for 2021 was $840K, a 88.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$7.71M -$6.62M -$7.72M -698% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $14K -$2.55M -$3.95M -282% Apr 1, 2023 Jun 30, 2023 10-K 2023-10-12
Q1 2023 $3.97M $1.36M +$1.23M +945% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.74M $100K +$357K Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-21
Q3 2022 $2.38M $1.11M +$1.37M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.02M $1.4M -$3.93M -73.7% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-12
Q1 2022 $4.95M $130K -$76K -36.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5.02M -$257K +$3.69M +93.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-21
Q3 2021 $1.33M -$259K +$490K +65.4% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q2 2021 $840K $5.33M +$1.84M +52.8% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-27
Q1 2021 -$1M $206K +$745K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$1.75M -$3.95M -$8.7M -183% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $6.95M -$749K -$555K -287% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $7.51M $3.49M +$13.4M Apr 1, 2020 Jun 30, 2020 10-K 2021-09-28
Q1 2020 -$5.93M -$539K -$342K -173% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$5.59M $4.75M +$4.86M Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$10.4M -$194K -$164K -563% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$10.3M -$9.95M -$14.3M -328% Apr 1, 2019 Jun 30, 2019 10-K 2020-10-06
Q1 2019 $4.04M -$197K -$4.9M -104% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $8.94M -$107K -$428K -133% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $9.37M -$29.2K -$140K -126% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $9.51M $4.37M +$6.02M Apr 1, 2018 Jun 30, 2018 10-K 2019-09-26
Q1 2018 $3.49M $4.71M +$5.06M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$1.57M $321K +$940K Oct 1, 2017 Dec 31, 2017 10-Q/A 2019-05-14
Q3 2017 -$2.51M $111K -$131K -54.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$2.38M -$1.65M +$347K +17.4% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-06
Q1 2017 -$2.73M -$357K +$3.69M +91.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$6.42M -$618K -$300K -94.3% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 -$6.12M $242K +$355K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$6.48M -$2M -$1.99M -48703% Apr 1, 2016 Jun 30, 2016 10-K 2017-08-31
Q1 2016 -$4.48M -$4.05M -$4.01M -11125% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$472K -$318K -$281K -748% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 -$191K -$113K -$75.8K -203% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$115K -$4.09K -$3.4K -491% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-01
Q1 2015 -$112K -$36.1K -$24.1K -201% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$87.5K -$37.5K -$36K -2403% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-11
Q3 2014 -$51.5K -$37.3K -$35.8K -2450% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$15.6K -$692 +$615 +47.1% Mar 1, 2014 May 31, 2014 10-Q 2014-07-10
Q1 2014 -$16.3K -$12K -$10.9K -981% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-19
Q4 2013 -$5.38K -$1.5K -$474 -46.2% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-12
Q3 2013 -$4.9K -$1.46K -$646 -79.1% Jun 1, 2013 Aug 31, 2013 10-K 2014-11-26
Q2 2013 -$4.26K -$1.31K -$452 -52.9% Mar 1, 2013 May 31, 2013 10-Q 2014-07-10
Q1 2013 -$3.81K -$1.11K -$252 -29.4% Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-11
Q4 2012 -$3.55K -$1.03K -$235 -29.7% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-10
Q3 2012 -$3.32K -$817 -$14 -1.74% Jun 1, 2012 Aug 31, 2012 10-K 2014-11-26
Q2 2012 -$3.31K -$855 -$161 -23.2% Mar 1, 2012 May 31, 2012 10-Q 2012-06-26
Q1 2012 -$3.14K -$856 -$334 -64% Dec 1, 2011 Feb 29, 2012 10-Q 2012-04-12
Q4 2011 -$2.81K -$791 +$373 +32% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-14
Q3 2011 -$3.18K -$803 Jun 1, 2011 Aug 31, 2011 10-K 2012-11-29
Q2 2011 -$694 Mar 1, 2011 May 31, 2011 10-Q 2012-06-26
Q1 2011 -$522 Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-12
Q4 2010 -$1.16K Sep 1, 2010 Nov 30, 2010 10-Q 2011-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.